The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-12-12), ResMed's share price is $242.51. ResMed's Book Value per Share for the quarter that ended in Sep. 2024 was $35.39. Hence, ResMed's PB Ratio of today is 6.85.
The historical rank and industry rank for ResMed's PB Ratio or its related term are showing as below:
RMD'
s PB Ratio Range Over the Past 10 Years
Min: 4.47 Med: 7.36 Max: 14.93
Current: 6.85
During the past 13 years, ResMed's highest PB Ratio was 14.93. The lowest was 4.47. And the median was 7.36.
RMD's PB Ratio is ranked worse than 85.13% of 787
companies
in the Medical Devices & Instruments industry
Industry Median: 2.34
vs RMD: 6.85
During the past 12 months, ResMed's average Book Value Per Share Growth Rate was 22.50% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 18.70% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 17.90% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 10.90% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of ResMed was 64.80% per year. The lowest was -4.70% per year. And the median was 17.00% per year.
Back to Basics: PB Ratio
ResMed PB Ratio Historical Data
The historical data trend for ResMed's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, ResMed's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ResMed's PB Ratio Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, ResMed's PB Ratio distribution charts can be found below:
* The bar in red indicates where ResMed's PB Ratio falls into.
ResMed PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
ResMed's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
ResMed PB Ratio Related Terms
Thank you for viewing the detailed overview of ResMed's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
RMD has been successfully added to your 